Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.92%11.86M | 5.73%11.09M | -6.96%9.4M | 18.48%43.41M | 3.53%11.13M | 20.70%11.64M | 21.58%10.49M | 26.17%10.1M | 47.90%36.64M | 18.73%10.75M |
| Cost of revenue | -12.98%516K | -10.56%576K | 25.10%623K | -11.98%2.35M | -42.54%616K | 9.01%593K | 40.00%644K | -57.87%498K | 23.83%2.67M | 16.40%1.07M |
| Gross profit | 2.72%11.34M | 6.79%10.52M | -8.62%8.78M | 20.87%41.06M | 8.63%10.51M | 21.39%11.04M | 20.54%9.85M | 40.72%9.6M | 50.20%33.97M | 19.00%9.68M |
| Operating expense | -5.42%10.39M | 6.29%10.22M | -6.85%9.34M | 19.78%40.89M | 3.15%10.27M | 36.76%10.98M | 21.27%9.62M | 21.94%10.02M | 23.45%34.14M | 22.80%9.96M |
| Other operating expenses | -5.42%10.39M | 6.29%10.22M | -6.85%9.34M | 19.78%40.89M | 3.15%10.27M | 36.76%10.98M | 21.27%9.62M | 21.94%10.02M | 23.45%34.14M | 22.80%9.96M |
| Operating profit | 1,516.95%954K | 28.07%292K | -33.65%-560K | 204.85%173K | 188.09%244K | -94.46%59K | -3.80%228K | 69.96%-419K | 96.72%-165K | -1,165.38%-277K |
| Net non-operating interest income (expenses) | -1.54%-1.06M | -40.56%-1.1M | -44.08%-1.11M | -70.18%-3.49M | -59.31%-1.1M | -59.51%-1.04M | -13.06%-779K | -769K | -12.13%-2.05M | -65.00%-693K |
| Non-operating interest income | ---- | ---- | ---- | -64.85%200K | ---- | ---- | ---- | ---- | 107.66%569K | ---- |
| Non-operating interest expense | 1.54%1.06M | 40.56%1.1M | 44.08%1.11M | 40.86%3.69M | 59.31%1.1M | 59.51%1.04M | 13.06%779K | --769K | 24.57%2.62M | -0.14%693K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 35.03%2.87M | -243.75%-92K | 1,483.04%1.55M | -91.41%2.51M | 238.02%432K | 67.22%2.13M | -99.77%64K | -124.78%-112K | 537.06%29.24M | -107.28%-313K |
| Special income (charges) | 359.11%3.37M | 359.42%3.38M | -643.43%-1.3M | -1.3M | ||||||
| Less:Write off | ---- | ---- | ---- | -359.11%-3.37M | -359.42%-3.38M | ---- | ---- | ---- | 3,842.42%1.3M | --1.3M |
| Other non-operating income (expenses) | 312.44%461K | 15.24%484K | -62.98%345K | 85.84%1.26M | 7,760.00%383K | -176.95%-217K | 33.76%420K | 240.15%932K | 34.52%678K | 98.23%-5K |
| Income before tax | 247.79%3.23M | -513.43%-411K | 161.41%226K | -85.52%3.82M | 228.62%3.33M | -52.77%929K | -100.24%-67K | 44.99%-368K | 1,457.38%26.4M | -175.02%-2.59M |
| Income tax | 0 | 0 | 0 | 28.94%1.82M | 36.41%1.82M | 0 | -93.33%1K | 0 | 106.44%1.41M | 98.51%1.33M |
| Net income | 247.79%3.23M | -504.41%-411K | 161.41%226K | -91.97%2.01M | 138.59%1.51M | -51.31%929K | -100.25%-68K | 45.32%-368K | 1,050.95%24.99M | -241.04%-3.92M |
| Net income continuous operations | 247.79%3.23M | -504.41%-411K | 161.41%226K | -91.97%2.01M | 138.59%1.51M | -51.31%929K | -100.25%-68K | 45.32%-368K | 1,050.95%24.99M | -241.04%-3.92M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 247.79%3.23M | -504.41%-411K | 161.41%226K | -91.97%2.01M | 138.59%1.51M | -51.31%929K | -100.25%-68K | 45.32%-368K | 1,050.95%24.99M | -241.04%-3.92M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 247.79%3.23M | -504.41%-411K | 161.41%226K | -91.97%2.01M | 138.59%1.51M | -51.31%929K | -100.25%-68K | 45.32%-368K | 1,050.95%24.99M | -241.04%-3.92M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 242.11%0.0065 | -700.00%-0.0008 | 171.43%0.0005 | -92.13%0.0041 | 137.80%0.0031 | -52.50%0.0019 | -100.17%-0.0001 | 50.00%-0.0007 | 1,047.27%0.0521 | -241.38%-0.0082 |
| Diluted earnings per share | 242.11%0.0065 | -700.00%-0.0008 | 171.43%0.0005 | -92.13%0.0041 | 137.80%0.0031 | -52.50%0.0019 | -100.17%-0.0001 | 50.00%-0.0007 | 1,047.27%0.0521 | -241.38%-0.0082 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.